pharma · Respiratory Syncytial Virus Infections · Asthma
MedImmune
MedImmune trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Gaithersburg, USA HQ
1987 Founded
896 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Gaithersburg, USA
- Founded
- 1987
- Employees
- 896
- Programs
- 9
- Drugs
- 7
- Patents
- 0
MedImmune clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to MedImmune programs — each row shows trial ID, program name, phase, status, and indication.
MedImmune trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for MedImmune.
-
Tralokinumab 300 mg, Q2W — Phase 2
Clinical update -
CAIV-T — Phase 2
Clinical update -
Durvalumab + Oleclumab — Phase 2
Clinical update -
MEDI8897 — Phase 2
Clinical update -
MEDI8968 600 mg IV, 300 mg SC — Phase 2
Clinical update -
MEDI9929 — Phase 2
Clinical update -
Monalizumab — Phase 2
Clinical update -
Motavizumab, palivizumab — Phase 2
Clinical update